MEROPENEM DIMER
UNII G6636F29A1

Substance Identification & Data

This profile provides standardized clinical and technical data for Meropenem Dimer, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G6636F29A1.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 166901-45-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

G6636F29A1

CAS Registry Number

166901-45-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MEROPENEM DIMER

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C34H50N6O10S2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XKGABVKQWYZCQF-WWQIJRAWSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

15232095

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N12C(=C([C@@H]([C@@]2([C@H](C1=O)[C@@H](C)O)[H])C)S[C@@H]3CN([C@@H](C3)C(=O)N(C)C)C([C@H]([C@@H](C)O)[C@@H]4NC(=C([C@@H]4C)S[C@@H]5CN[C@@H](C5)C(=O)N(C)C)C(=O)O)=O)C(=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Meropenem Dimer. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

MEROPENEM DIMER

MEROPENEM TRIHYDRATE IMPURITY B [EP IMPURITY]

Systematic Nomenclature

(4R,5S,6S)-3-(((3S,5S)-1-((2S,3R)-2-((2S,3R)-5-CARBOXY-4-(((3S,5S)-5-((DIMETHYLAMINO)CARBONYL)PYRROLIDIN-3-YL)SULFANYL)-3-METHYL-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXYBUTANOYL)-5-((DIMETHYLAMINO)CARBONYL)PYRROLIDIN-3-YL)SULFANYL)-6-((1R)-1-HYDROXYETHYL)-4-METHYL-7-OXO-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID

SYS

(4R,5S,6S)-3-(((3S,5S)-1-((2S,3R)-2-((2S,3R)-5-CARBOXY-4-(((3S,5S)-5-(DIMETHYLCARBAMOYL)PYRROLIDIN-3-YL)THIO)-3-METHYL-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXYBUTANOYL)-5-(DIMETHYLCARBAMOYL)PYRROLIDIN-3-YL)THIO)-6-((R)-1-HYDROXYETHYL)-4-METHYL-7-OXO-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID

SYS

1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID, 3-((1-(2-(5-CARBOXY-4-((5-((DIMETHYLAMINO)CARBONYL)-3-PYRROLIDINYL)THIO)-2,3-DIHYDRO-3-METHYL-1H-PYRROL-2-YL)-3-HYDROXY-1-OXOBUTYL)-5-((DIMETHYLAMINO)CARBONYL)-3-PYRROLIDINYL)THIO)-6-(1-HYDROXYETHYL)-4-METHYL-7-OXO-, (4R-(3(1(2S*(2S*,3R*,4(3S*,5S*)),3R*),3S*,5S*),4.ALPHA.,5.BETA.,6.BETA.(R*)))-

SYS

External Clinical & Regulatory Resources

Previous UNIIG65T7F353H

Next UNIIG66388U44D